Optimal Dose and Safety of Intravenous Favipiravir in Hospitalized Patients With <scp>COVID</scp> ‐19: A Dose‐Escalating, Randomized Controlled Phase Ib Study

Authors

Publication Details

Journal
Apollo (University of Cambridge)
Published
2025-10-08
Primary Topic
COVID-19 Clinical Research Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Optimal Dose and Safety of Intravenous Favipiravir in Hospitalized Patients With COVID ‐19: A Dose‐Escalating, Randomized Controlled Phase Ib Study

Henry Pertinez, Tom Fletcher, Orod Osanlou, Thomas Jaki et al.
Apollo (University of Cambridge)
COVID-19 Clinical Research Studies
article

Optimal Dose and Safety of Intravenous Favipiravir in Hospitalized Patients With COVID ‐19: A Dose‐Escalating, Randomized Controlled Phase Ib Study

Henry Pertinez, Tom Fletcher, Orod Osanlou, Thomas Jaki, Yvanne Enever, Helen Reynolds, Laura Dickinson, David G. Lalloo, Pavel Mozgunov, Jennifer Gibney, Michelle Tetlow, Elizabeth Challenger, Tim Rowland, Colin Hale, Rebecca Lyon, Margaret Irwin, Justin Chiong, Karim Dhamani, Callum Kelly, William Wood, Laura J Else, Gareth Griffiths, Julian A Hiscox, Geoffrey Saunders, Lauren Walker, Andrew Owen, Saye H Khoo, William Greenhalf, Katie Bullock, Richard FitzGerald, Victoria Shaw, Michael Jacobs
article en

Abstract

No abstract available for this paper.
Apollo (University of Cambridge)
Openalex Percentile: Top 26%
COVID-19 Clinical Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.